Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2024 Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2024 Earnings Call Transcript August 8, 2024

Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is $-0.10115, expectations were $-0.11.

Operator: Hello, everyone, and welcome to today’s Xeris Biopharma Second Quarter 2024 Financial Results Call. My name is Drew, and I’ll be your operator today. During today’s call there will be a Q&A session. [Operator Instructions]. I will now turn the call over to Allison Wey, Senior...